The application of polysaccharide hemospheres in endoscopic submucosal dissection of upper digestive tract and comparison with lyophilizing thrombin powder to prevent rehaemorrhagia

Hui DING,Huimin CHEN,Yunjia ZHAO,Yao ZHANG,Xiaobo LI,Jingyuan FANG,Zhizheng GE
DOI: https://doi.org/10.3969/j.issn.1006-5709.2018.10.016
2018-01-01
Abstract:Objective To investigate the clinical effect of polysaccharide hemospheres on hemostasis and preventing rehaemorrhagia in upper gastrointestinal endoscopic submucosal dissection ( ESD) . Methods Sixty-seven hospitalized patients who underwent ESD for upper gastrointestinal tract mucosal lesions were selected. Among them, 32 cases still had bleeding wounds after regular treatment, and they were treated with polysaccharide hemospheres. Thirty-five cases had clear wounds and used lyophilizing thrombin powder to prevent rehaemorrhagia. Time of hemostasis and the success rate of hemostasis were observed in polysaccharide hemospheres. After 30 days of follow-up, the safety was observed. Results In the 32 patients treatment with polysaccharide hemospheres, the average dosage during operation was (1. 97 ± 1.04)g, the average hemostasis time was (83.81 ±59.94)s, and the success rate of hemostasis was 96.88%. There were no significant differences in hemoglobin, platelet count, prothrombin time, INR, partial thromboplastin time and thrombin time in patients with preoperative and postoperative (P>0. 05). After the operation, no rehaemorrhagia was found in polysaccharide hemospheres group, but 4 cases of rehaemorrhagia were found in lyophilizing thrombin powder group, the difference was statistically significant (P<0. 05). Conclusion The effect of polysaccharide hemospheres in the ESD of upper gastrointestinal tract is significant and safe. Compared with lyophilizing thrombin powder, the risk of rehaemorrhagia is significantly reduced.
What problem does this paper attempt to address?